排序
胰高血糖素样肽-1受体激动剂(GLP-1RA)临床应用医药专家共识
胰高血糖素样肽-1受体激动剂(GLP-1RA)临床应用医药专家共识(广东省药学会)关键词:胰高血糖素样肽-1受体激动剂;临床应用;专家共识A Joint Expert Consensus of Clinicians and Pharmacists on...
2023INCOG2.0指南:创伤性脑损伤后的认知康复—第Ⅳ部分:认知沟通与社会认知障碍
Head Tramma RebabilV%l.38,No.1,pp.65-82OPENCopyright 2023 The Authors.Published by Wolters Kluwer Health,Inc.INCOG 2.0 Guidelines for CognitiveRehabilitation Following TraumaticBra...
2023更新—2019NICE指南:妊娠期高血压的诊断和管理[NG.133]
NICENational Institute forHealth and Care ExcellenceNICE贝guidelineHypertension inpregnancy:diagnosis andmanagementNICE guidelinePublished:25 June 2019www.nice.org.uk/guidance/ng13...
2023EAU指南:睾丸癌(更新版)
ARTICLE IN PRESSEUROPEAN UROLOGY xxx (2023)xxxavailable at www.sciencedirect.comjournal homepage:www.europeanurology.comEUROPEANeaEuropean Association of UrologyReview -Testis Canc...
2023ESGOISSVDECSVDEFC共识声明:阴道上皮内瘤变的管理
ORIGINAL RESEARCH ARTICLE:VULVA AND VAGINAOPENThe European Society of Gynaecological Oncology (ESGO),the International Society for the Study of Vulvovaginal Disease(ISSVD),the Euro...
2023NICE技术鉴定指导意见:他法西单抗联合来那度胺治疗复发或难治性弥漫性大B细胞淋巴瘤[TA883]
NENatonalinsutute forHealth and Care ExcellenceNICE贝guidanceTafasitamab withlenalidomide for treatingrelapsed or refractorydiffuse large B-celllymphomaTechnology appraisal guidanc...
日本《成人低危型甲状腺微小乳头状癌主动监测与管理共识声明(2021版)》解读
中国实用外科杂志2023年2月第43卷第2期·159·指南(共识)解读D0L:l0.195385.cjps.issnl005-2208.2023.02.08日本《成人低危型甲状腺微小乳头状癌主动监测与管理共识声明(2021版)》解读刘俊松,...
2023ESPEN实践指南:家庭肠外营养
Clinical Nutrition 42 (2023)411-430Contents lists available at ScienceDirectCLINICALNUTRITIONClinical NutritionELSEVIERjournal homepage:http://www.elsevier.com/locate/cInuESPEN Gui...
中国临床肿瘤学会乳腺癌诊疗指南(2025版)更新要点(江泽飞)(已优化)
中国临床肿瘤学会(CSCO)乳腺癌诊疗指南2025版更新要点CSCO中国临床肿瘤学会(CSCO)乳腺癌诊疗指南2025GUIOEUINES OF CHINESE SOCIETY OF CLINICAL ONCCLCST ICSCOBREAST CANCER2025中四■里种雁...
临床应用医药专家共识-f919d051df-pdf-1.webp)


![2023更新—2019NICE指南:妊娠期高血压的诊断和管理[NG.133]-医知素材库](https://cdn.jiaoyuwz.com/2023更新—2019NICE指南:妊娠期高血压的诊断和管理[NG.133]-75fee50fe6-pdf-1.webp)
-30892a63c1-pdf-1.webp)

![2023NICE技术鉴定指导意见:他法西单抗联合来那度胺治疗复发或难治性弥漫性大B细胞淋巴瘤[TA883]-医知素材库](https://cdn.jiaoyuwz.com/2023NICE技术鉴定指导意见:他法西单抗联合来那度胺治疗复发或难治性弥漫性大B细胞淋巴瘤[TA883]-221c392c25-pdf-1.webp)
》解读-e8dbbd1400-pdf-1.webp)

更新要点(江泽飞)(已优化)-55fc8489b3-pdf-1.webp)
